COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?-An Insight from the GeroCovid Registry

THROMBOSIS AND HAEMOSTASIS(2022)

引用 21|浏览0
暂无评分
摘要
Introduction Atrial fibrillation (AF), the most frequent arrhythmia of older patients, associates with serious thromboembolic complications and high mortality. Coronavirus disease 2019 (COVID-19) severely affects aged subjects, determining an important prothrombotic status. The aim of this study was to evaluate mortality-related factors in older AF patients with COVID-19. Methods Between March and June 2020, we enrolled >= 60 year-old in-hospital COVID-19 patients ( n= 806) in GeroCovid, a multicenter observational study promoted by the Italian Society of Gerontology and Geriatric Medicine. Results The prevalence of AF was 21.8%. In-hospital mortality was higher in the AF group (36.9 vs. 27.5%, p =0.015). At admission, 51.7, 10.2, and 38.1% of AF cases were taking, respectively, oral anticoagulants (OACs), antiplatelet agents, and no antithrombotic therapy. During hospitalization, 51% patients switched to low-molecular-weight heparins. AF patients who survived were younger (818 vs. 84 +/- 7 years; p =0.002) and had a lower CHA (2) DS (2) -VASc score (3.9 +/- 1.6 vs. 4.4 +/- 1.3; p =0.02) than those who died. OAC use before (63.1 vs. 32.3%; p <0.001) and during hospitalization (34.0 vs. 12.7%; p =0.002) was higher among survivors. At multivariable analysis, lower age, higher self-sufficiency, less severe initial COVID-19 presentation, and the use of vitamin K antagonists (odds ratio [OR]=0.16, 95% confidence interval [CI]: 0.03-0.84) or direct OACs (OR=0.22, 95% CI: 0.08-0.56) at admission, or the persistence of OAC during hospitalization (OR=0.05, 95% CI: 0.01-0.24), were associated with a lower chance of in-hospital death. Conclusion AF is a prevalent and severe condition in older COVID-19 patients. Advanced age, dependency, and relevant clinical manifestations of disease characterized a worse prognosis. Preadmission and in-hospital anticoagulant therapies were positively associated with survival.
更多
查看译文
关键词
atrial fibrillation, COVID-19, DOACs, aged, oral anticoagulants
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要